The Norton Lab will collaborate with Biotech company Q-Vant Biosciences to develop a new oral vaccine platform for prevention of multiple infectious diseases. The platform…
Dr. Elizabeth Norton and Dr. Jay Kolls were awarded an NIH contract to bring a nasal spray pneumonia vaccine to Phase One clinical trial. This…
New NIH R56 grant on ETEC vaccination with dmLT Adjuvant. The objective of this proposal is to test samples from an ETEC vaccine clinical trial and seek…
With the advent of the COVID-19 pandemic, the Norton lab joined forces with other Tulane Investigators including Dr. James Robinson, Dr. John Schieffelin, Dr. Kevin…